The joint health-care venture between Amazon, J.P. Morgan and Berkshire Hathaway is primarily focused on simplifying health insurance, according to newly released court testimony from Chief Operating Officer Jack Stoddard. » Read More
By: Christina Farr
Amazon's senior health leader, Taha Kass-Hout, talks up the company's advances in artificial intelligence. » Read More |
By: Sara Salinas
The anecdote reported by Vanity Fair sheds light on the chaos that consumed Theranoss final stretch. » Read More |
Johnson & Johnson has received subpoenas from the Justice Department and the SEC related to litigation involving alleged asbestos contamination in its Baby Powder line. » Read More |
Pinterest has taken the boldest step thus far among the largest tech giants in blocking bad health advice.
CVS gave its 2019 earnings forecast, which fell well short of expectations, disappointing investors and stoking fears about CVS' core business.
Bristol-Myers Squibb confirms Starboard's stake in the company and says the $74 billion deal to acquire cancer drugmaker Celgene is "on track" to close during the third quarter.
U.S. healthcare plan and pharmacy benefits manager Magellan Health will explore selling itself after coming under pressure to do so from activist hedge fund Starboard Value LP, people familiar with the matter said on Wednesday.
A company that charged patients thousands of dollars for infusions of blood plasma from younger donors said Tuesday that it had stopped treating patients after the Food and Drug Administration warned consumers against such treatments, purported to prevent aging and memory loss, NBC News reports.
CVS Health shares crater after the company disappointed investors with a lower-than-expected earnings forecast for the year as it integrates Aetna.
The FDA is advising against "young blood" infusions, in which people are infused with plasma from young donors. It warns consumers that clinics are making unproven claims that the treatment can reverse aging.
Medical device maker Medtronic on Tuesday beat Wall Street estimates for quarterly profit, driven by higher sales in its surgical products unit and restorative therapies group.
As people shop online more, CVS and Walgreens are trying to give people reasons to keep coming into their stores.
A foldable drone has been developed by researchers at the University of Zurich to assist with search and rescue missions.
Techies are finding new uses for consumer devices to help monitor their aging parents, who are increasingly opting to live independently.
Apple just brought on a new leader for its home unit.
The New York City Health Department plans to step up its campaign — with violations and fines — against restaurants offering CBD.
Judy Faulkner is not going to sell her company Epic Systems to Apple anytime soon. "We're not going to do that," she said at a conference this week.
Cannabis producer Canopy Growth was set to rally Friday after it reported third-quarter revenue rose 282 percent over the last year.
"I've never seen a sector have the political tailwinds, the economic tailwinds, and the wellness tailwinds that this sector potentially has," said legendary investor Danny Moses.
Get the best of CNBC in your inbox
Data also provided by 
